One shot to rule them all? new combo vaccine trial for kids begins
NCT ID NCT07203755
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial is testing a new vaccine that combines protection against several serious childhood diseases: diphtheria, tetanus, whooping cough, meningitis, and Hib. The study involves 260 children aged 2 months to 6 years to check the vaccine's safety and immune response. Researchers are comparing different doses and a placebo to find the best approach.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Liangyuan District Center for Disease Control and Prevention, Shangqiu City
RECRUITINGShangqiu, Henan, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new vaccine safely shield babies from meningitis?
- Can a new vaccine shield older kids and adults from three deadly infections?
- Can a Five-Part vaccine bolster protection against three serious infections?
- Could a Freeze-Dried vaccine shield all ages from hib?
- Will a single DTP vaccine dose protect for a decade? study tracks antibodies
- Could a single meningitis shot protect for years? a study investigates